Hygeia Healthcare Holdings Co., Limited disclosed a further on-market share repurchase on 2 October 2026, acquiring 26,800 ordinary shares at prices between HKD 9.375 and HKD 9.38, for a total consideration of HKD 0.25 million.

Following the transaction: • Issued shares (excluding treasury shares) declined 0.0044 % to 602.43 million. • Treasury shares increased to 16.07 million, leaving total issued shares unchanged at 618.50 million. • The volume-weighted average repurchase price was HKD 9.379 per share.

Mandate utilisation: • The repurchase forms part of the mandate approved on 26 June 2026, which permits the company to buy back up to 60.77 million shares. • Cumulative repurchases under this mandate now stand at 5.31 million shares, equivalent to 0.87 % of the issued share capital at the mandate date. • A 30-day moratorium prohibits new share issues or sales of treasury shares until 1 November 2026.

All repurchased shares are being held in treasury; none have been cancelled to date. The board confirmed that the transaction complied with Hong Kong Stock Exchange listing rules and relevant regulatory requirements.